91 related articles for article (PubMed ID: 10370674)
1. Relationship between ornithine decarboxylase gene abnormalities and human hepatocarcinogenesis.
Koh N; Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Tanaka T; Kinoshita H; Yano Y; Otani S
Hepatogastroenterology; 1999; 46(26):1100-5. PubMed ID: 10370674
[TBL] [Abstract][Full Text] [Related]
2. Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Koh N; Kobayashi K; Yano Y; Otani S
Cancer Res; 1995 Aug; 55(16):3500-3. PubMed ID: 7627954
[TBL] [Abstract][Full Text] [Related]
3. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Kinoshita H; Otani S
Hepatology; 1994 Nov; 20(5):1179-86. PubMed ID: 7927250
[TBL] [Abstract][Full Text] [Related]
4. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
[TBL] [Abstract][Full Text] [Related]
5. Ornithine decarboxylase activity in the non-cancerous hepatic tissue of patients with hepatocellular carcinoma.
Kubo S; Tamori A; Omura T; Ikebe T; Wakasa K; Hirohashi K; Kinoshita H; Otani S
Hepatogastroenterology; 2000; 47(33):820-3. PubMed ID: 10919038
[TBL] [Abstract][Full Text] [Related]
6. Polyamine metabolism and recurrence after resection for hepatocellular carcinoma.
Kubo S; Tamori A; Tanaka H; Takemura S; Shuto T; Hirohashi K; Kinoshita H; Nishiguchi S
Hepatogastroenterology; 2004; 51(55):208-10. PubMed ID: 15011865
[TBL] [Abstract][Full Text] [Related]
7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
9. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
10. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
11. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
14. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.
Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y
Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
16. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma.
Yan J; Yu Y; Wang N; Chang Y; Ying H; Liu W; He J; Li S; Jiang W; Li Y; Liu H; Wang H; Xu Y
Oncogene; 2004 Mar; 23(10):1939-49. PubMed ID: 14981537
[TBL] [Abstract][Full Text] [Related]
17. Survivin gene expression in chronic liver disease and hepatocellular carcinoma.
Montorsi M; Maggioni M; Falleni M; Pellegrini C; Donadon M; Torzilli G; Santambrogio R; Spinelli A; Coggi G; Bosari S
Hepatogastroenterology; 2007; 54(79):2040-4. PubMed ID: 18251156
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
20. The alteration of cytokeratin 18 molecule and its mRNA expression during tumor transformation in hepatoma.
Liu YH; Pei RJ; Yeh CC; Lee KY; Yeh KT; Hsu YH; Ho CC; Lai YS
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):243-53. PubMed ID: 9261884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
